This study is a pragmatic open-label international randomized trial comparing therapeutic
dose intravenous unfractionated heparin (UFH) to standard care venous thromboprophylaxis in
patients diagnosed with septic shock.
Phase:
Phase 2
Details
Lead Sponsor:
University of Manitoba
Collaborators:
Canadian Institutes of Health Research (CIHR) CancerCare Manitoba